Edwards Lifesciences Corp
EW
62 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 8 9:24 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $85.65 | $53.0K | 40,033.91(D) | View → |
| Sep 11, 2026 | Sep 11 11:15 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $87.51 | $54.2K | 40,033.91(D) | View → |
| Aug 31, 2026 | Aug 31 9:47 PM | Andrew M. DahlSVP, Corporate Controller | Sale | 544 | $91.06 | $49.5K | 14,868.41(D) | View → |
| Aug 31, 2026 | Aug 31 8:15 PM | Dahl Andrew M. | Proposed Sale | 544 | $91.06 | $49.5K | — | View → |
| Aug 28, 2026 | Aug 28 8:32 PM | Annette BrulsCVP, EMEACLA | Sale | 2,644 | $89.98 | $237.9K | 17,984(D) | View → |
| Aug 28, 2026 | Aug 28 8:18 PM | Bruls Annette | Proposed Sale | 2,644 | $89.98 | $237.9K | — | View → |
| Aug 26, 2026 | Aug 26 10:36 PM | Daveen ChopraCVP, TMTT, Surgical & IHFM | Sale | 31,800 | $91.02 | $2.9M | 44,324(D) | View → |
| Aug 26, 2026 | Aug 26 10:00 PM | Wayne MarkowitzCVP, JAPAC | Sale | 1,240 | $91.47 | $113.4K | 20,293.558(D) | View → |
| Aug 26, 2026 | Aug 26 8:02 PM | Markowitz Wayne | Proposed Sale | 1,240 | $91.47 | $113.4K | — | View → |
| Aug 26, 2026 | Aug 26 8:01 PM | Chopra Daveen | Proposed Sale | 31,800 | $91.02 | $2.9M | — | View → |
| Aug 11, 2026 | Aug 11 9:07 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $92.03 | $57.0K | 40,033.91(D) | View → |
| Aug 11, 2026 | Aug 11 8:07 PM | Lippis Daniel J. | Proposed Sale | 1,857 | $92.03 | $170.9K | — | View → |
| Jul 30, 2026 | Jul 30 9:30 PM | Wayne MarkowitzCVP, JAPAC | Sale | 146.313 | $86.03 | $12.6K | 21,533.558(D) | View → |
| Jul 30, 2026 | Jul 30 8:20 PM | Ullem Scott B. | Proposed Sale | 50,000 | $92.50 | $4.6M | — | View → |
| Jul 30, 2026 | Jul 30 8:19 PM | Markowitz Wayne | Proposed Sale | 147 | $85.63 | $12.6K | — | View → |
| Jul 28, 2026 | Jul 28 11:40 PM | Wayne MarkowitzCVP, JAPAC | Sale | 9,628 | $85.06 | $819.0K | 21,679.871(D) | View → |
| Jul 28, 2026 | Jul 28 8:18 PM | Markowitz Wayne | Proposed Sale | 9,628 | $85.06 | $819.0K | — | View → |
| Jul 27, 2026 | Jul 27 10:59 PM | Bernard J ZovighianDirector, CEO | Sale | 2,920.551 | $83.93 | $245.1K | 8,915.65(I) | View → |
| Jul 27, 2026 | Jul 27 8:08 PM | Zovighian Bernard J | Proposed Sale | 2,921 | $83.92 | $245.1K | — | View → |
| Jul 10, 2026 | Jul 10 9:04 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $91.70 | $56.8K | 40,033.91(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | May 5 11:08 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 0(D) | View → |
| May 4, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 0(D) | View → |
| May 1, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 1,019(D) | View → |
| Apr 9, 2026 | Apr 9 11:34 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 13,000(D) | View → |
| Apr 6, 2026 | Apr 7 12:42 AM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 2,038(D) | View → |
| Apr 2, 2026 | Apr 2 9:13 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 22,680 | $59.26 | 0(D) | View → |
| Mar 11, 2026 | Mar 11 9:15 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 26,000(D) | View → |
| Mar 11, 2026 | Mar 11 9:10 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 3,057(D) | View → |
| Mar 2, 2026 | Mar 2 10:50 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 11,340 | $59.26 | 22,680(D) | View → |
| Feb 12, 2026 | Feb 13 10:37 PM | Bernard J ZovighianDirector, CEO | Option Exercise | 25,350 | $59.26 | 0(D) | View → |
← Previous
Page 2 of 2